Clinical Trials in Versailles, France
11 recruiting
Showing 1–12 of 12 trials
Recruiting
Phase 3
Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
Colon Cancer
University Hospital, Rouen232 enrolled28 locationsNCT06107920
Recruiting
Phase 3
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland227 enrolled119 locationsNCT07075016
Recruiting
Phase 3
Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome824 enrolled64 locationsNCT06918002
Recruiting
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma
Multiple Myeloma
Intergroupe Francophone du Myelome180 enrolled20 locationsNCT05208086
Recruiting
Phase 2
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia
AML, AdultRefractory AMLRelapsed Adult AML+2 more
French Innovative Leukemia Organisation33 enrolled20 locationsNCT06022003
Recruiting
Not Applicable
Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy
Leukemia,Myeloid, Chronic
University Hospital, Clermont-Ferrand321 enrolled17 locationsNCT06130787
Recruiting
Phase 3
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
Chronic Myeloid LeukemiaTyrosine Kinase Inhibitors
Poitiers University Hospital140 enrolled20 locationsNCT05753384
Recruiting
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine
AML, Adult
French Innovative Leukemia Organisation230 enrolled42 locationsNCT06263387
Recruiting
Phase 1Phase 2
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris64 enrolled13 locationsNCT05580861
Recruiting
Chronic Myeloid Leukemia (CML) Real-Life Database
Chronic Myeloid Leukemia (CML)
University Hospital, Clermont-Ferrand3,500 enrolled14 locationsNCT05963061
Recruiting
Not Applicable
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors
Chronic Myeloid Leukemia (CML)Chronic Phase
University Hospital, Clermont-Ferrand160 enrolled16 locationsNCT03481868
Recruiting
Risk of Maternal Depression From 1 Year to 4 Years Postpartum in Yvelines
Post Partum Depression
Centre Médical Porte Verte800 enrolled1 locationNCT06042972